Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
source: pixabay.com
Findings of the interim analysis from KEYNOTE-177 were presented at the virtual scientific meeting of the American Society of Clinical Oncology (ASCO) held in May 2020. The lead author…
Continue Reading
Keytruda Improves Progression-Free Survival for Advanced Colorectal Cancer Patients
Nicox SA, an international ophthalmology company, recently announced a Phase 3 clinical trial for NCX 470 to lower intraocular eye pressure. The article recently appeared in Eye Wire News. The…
Continue Reading
Looking Good: A Phase 3 Trial for Open-Angle Glaucoma
source: pixabay.com
NAMI, the nation’s foremost agency for mental health, defines depression as “more than just feeling sad” or just a “rough patch” in our lives. Doctor Susan Noonan reported on…
Continue Reading
Are You Feeling Depressed During the COVID-19 Pandemic?
source: pixabay.com
According to a recent article in Medscape, the FDA has issued accelerated approval for Bristol-Myers Squibb's Pomalyst (pomalidomide). Pomalyst was approved as the first new oral treatment for AIDS-related…
Continue Reading
The Only Oral Drug for AIDS-Related Kaposi Sarcoma Has Been FDA Approved
Daily use of Nuplazid (pimavanserin) leads to strong and sustained reductions in the frequency and severity of hallucinations and delusions in people with Parkinson’s disease psychosis, according to data from…
Continue Reading
Nuplazid Shows Sustained Easing of Psychosis in Patients in Phase 3 Trial
source: pixabay.com
In a recent article that appeared in Science Magazine, Amy Boland described her twelve-year quest to find a cure for the cancer that invaded her lymph system. At first,…
Continue Reading
Amy Boland’s Last Option Was a Bispecific Antibody Drug for Lymphoma. It Worked.
source: pixabay.com
A team of researchers from the Perelman School of Medicine and several other institutions recently reported a significant reduction in tumor growth in myeloid immune cells using an experimental…
Continue Reading
New Drug Ready for Human Trials After Shrinking Tumor Growth by 80 Percent
source: pixabay.com
In 2015 families in Wales and England were given the good news that tolvaptan (JINARC®), which was developed for autosomal dominant polycystic kidney disease (ADPKD), will be available within one…
Continue Reading
Reporting Two Years of Follow-up Treating ADPKD
Dr. Changcheng Zheng of the University of Science, China, recently spoke to Cancer Network about a case study indicating that tocilizumab (Actemra) could effectively treat people with multiple myeloma…
Continue Reading
Sixty Year Old Multiple Myeloma Patient in Wuhan, China Treated Successfully with Tocilizumab for COVID-19
Scientists at the Tohoku University reported in Asia Research News that antibodies are responsible for the difference between various disorders and multiple sclerosis (MS). These disorders affect the myelin sheath…
Continue Reading
Scientists Have Discovered a New Approach to Diagnosing Multiple Sclerosis
source: pixabay.com
What would motivate a man, who has been living with amyotrophic lateral sclerosis (ALS) for twenty years, to accept an invitation to become part of a five-man team and…
Continue Reading
This ALS Patient Rowed 3000 Miles Across the Atlantic Ocean
source: pixabay.com
In an article in Medical Xpress, Japanese doctors have performed a “first” by transplanting liver cells (made with embryonic stem cells) into a newborn. The six-day-old infant was diagnosed with…
Continue Reading
Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder
source: pixabay.com
After six decades of attempting to solve chronic organ rejection, researchers at Houston’s Methodist Hospital and Pittsburgh University have met the challenge. According to an article in Medical Xpress,…
Continue Reading
This Breakthrough Finding Could put an End to Chronic Organ Rejection
According to a recent article in Nature, many countries are anticipating an immediate response from newly developed antibody tests. These tests are slated to bring relief from the lockdown and…
Continue Reading
COVID-19 Antibody Tests: Are They Oversold?
Patient Worthy is honored to present Dr. Eunice Wang, who has herewith responded to questions from our readers about the effect of the COVID-19 virus on their cancer treatment. Dr.…
Continue Reading
An Interview With Dr. Eunice Wang Discussing COVID-19 and Blood Cancer
As reported in Technology Network, a group of international scientists from the VIB-UGent Center presented a new antigen immune cell. These antigen-presenting cells belong to a group of dendritic cells…
Continue Reading
Dendritic Cells Play an Important Role in Respiratory Infections
A recent article in US News and World Report gives an account of the first patient to have reprogrammed cells successfully implanted in his brain. The patient’s doctors reported that…
Continue Reading
Doctors Report First Ever Successful Transplant of Reprogrammed Cells into the Brain of a Parkinson’s Patient
source: pixabay.com
A recent article in Parkinson’s News Today described new findings associated with mutations in the LRRK2 gene, which are associated with Parkinson’s disease (PD). Indications are that patients with…
Continue Reading
Research Links Metabolic Syndrome in Parkinson’s Patients Who Have LRRK2 Mutations
source: pixabay.com
Biological robots, commonly known as biobots, mimic the actions of other organisms (e.g. jumping or swimming). Biobots are composed of artificial materials and also organic material. As published in…
Continue Reading
Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?
source: pixabay.com
Immunotherapies are in the forefront for treating autoimmune diseases and cancer. Northwestern University and the University of California San Francisco conducted a study using genes that have the potential…
Continue Reading
UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity. The white knob on the left shows demyelination of a nerve fiber end.…
Continue Reading
Not All Multiple Sclerosis-like Diseases are Alike
While the number of cases is extremely small, a University of California-San Diego professor is urging health officials to expand alerts about the mysterious illness previously seen only in children.…
Continue Reading
Young adults are also affected by Kawasaki-like disease linked to coronavirus, doctors say
Bridging the Voice of ALS Patients | ATSDR Bridging the Voice of ALS Patients Because learning more about ALS is an important step in the battle to defeat it, the…
Continue Reading
Bridging the Voice of ALS Patients | Atsdr
Promising new drug target for autoimmune and allergic diseases revealed Credit: The Babraham Institute A study led by researchers at the Babraham Institute in collaboration with the Wellcome Sanger Institute…
Continue Reading
Uncovering how ‘dark matter’ regions of the genome affect inflammatory diseases
According to CNN, the CDC recently sent out a health advisory to doctors across the United States alerting them of a new syndrome affecting children in eighteen states, Washington, D.C.,…
Continue Reading
CDC Warns of New Syndrome Affecting Children Associated With COVID-19